Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Balchem (BCPC) EBT (2016 - 2025)

Balchem (BCPC) has disclosed EBT for 16 consecutive years, with $50.0 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 12.48% to $50.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $199.0 million, a 19.57% increase, with the full-year FY2025 number at $50.0 million, down 69.94% from a year prior.
  • EBT was $50.0 million for Q4 2025 at Balchem, down from $52.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $52.0 million in Q3 2025 to a low of $25.8 million in Q4 2022.
  • A 5-year average of $38.1 million and a median of $37.2 million in 2022 define the central range for EBT.
  • Peak YoY movement for EBT: decreased 22.62% in 2023, then soared 33.72% in 2024.
  • Balchem's EBT stood at $33.1 million in 2021, then fell by 22.23% to $25.8 million in 2022, then increased by 29.06% to $33.3 million in 2023, then soared by 33.72% to $44.5 million in 2024, then rose by 12.48% to $50.0 million in 2025.
  • Per Business Quant, the three most recent readings for BCPC's EBT are $50.0 million (Q4 2025), $52.0 million (Q3 2025), and $49.0 million (Q2 2025).